|
Market Closed -
Bombay S.E.
06:02:24 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 29.35 INR | +4.82% |
|
+5.12% | -13.55% |
| Market Cap | 1.11B 11.71M 10.08M 9.47M 8.64M 16.23M 16.34M 112M 43.6M 565M 43.96M 43.01M 1.87B | P/E 2024 |
-49.7x | P/E 2025 | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.51B 15.83M 13.62M 12.79M 11.68M 21.93M 22.09M 152M 58.92M 764M 59.41M 58.12M 2.53B | EV / Sales 2024 |
2.98x | EV / Sales 2025 | 2.02x |
| Free-Float |
9.04% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.82% | ||
| 1 week | +5.12% | ||
| Current month | -7.15% | ||
| 1 month | -5.32% | ||
| 3 months | -19.59% | ||
| 6 months | -6.88% | ||
| Current year | -13.55% |
| 1 week | 27.04 |  | 29.9 |
| 1 month | 26.1 | | 32.5 |
| Current year | 23.2 | | 43.28 |
| 1 year | 23.2 | | 43.28 |
| 3 years | 23.2 | | 86.85 |
| 5 years | 23.2 | | 86.85 |
| 10 years | 8.85 | | 86.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sameer Goel
CEO | Chief Executive Officer | 51 | 2016-03-28 |
Mani Jain
DFI | Director of Finance/CFO | - | 2026-04-26 |
| Compliance Officer | 46 | 2018-09-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Sameer Goel
CHM | Chairman | 51 | 2016-03-28 |
Avinash Prabhat
BRD | Director/Board Member | 30 | 2026-04-03 |
Reema Goyal
BRD | Director/Board Member | 31 | 2026-04-03 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.82% | +5.12% | -21.67% | -16.12% | 13.86M | |
| -1.52% | -7.86% | +57.90% | +111.09% | 1,047B | |
| -0.82% | -1.62% | +50.05% | +62.37% | 646B | |
| +0.37% | -3.22% | +21.87% | +72.88% | 451B | |
| -1.64% | -4.75% | +35.59% | +35.54% | 355B | |
| -0.39% | -2.76% | +21.39% | +38.01% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -0.59% | -3.15% | +49.83% | +67.70% | 234B | |
| -1.05% | -2.29% | -19.91% | -54.10% | 203B | |
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | |
| Average | +0.12% | -2.38% | +22.64% | +42.02% | 365.93B | |
| Weighted average by Cap. | -0.12% | -3.46% | +36.91% | +64.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.05B 11.02M 9.48M 8.91M 8.13M 15.27M 15.38M 106M 41.04M 532M 41.38M 40.48M 1.76B | 1.19B 12.5M 10.75M 10.1M 9.22M 17.32M 17.44M 120M 46.53M 603M 46.92M 45.9M 2B |
| Net income | -53.09M -558K -480K -451K -412K -773K -779K -5.35M -2.08M -26.92M -2.09M -2.05M -89.15M | 96.12M 1.01M 869K 817K 746K 1.4M 1.41M 9.68M 3.76M 48.75M 3.79M 3.71M 161M |
| Net Debt | 494M 5.19M 4.46M 4.19M 3.83M 7.19M 7.24M 49.71M 19.32M 250M 19.48M 19.05M 829M | 392M 4.11M 3.54M 3.33M 3.04M 5.7M 5.74M 39.42M 15.32M 199M 15.45M 15.11M 657M |
Employees
250
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | ₹29.35 | +4.82% | 3,195 |
| 26-08-28 | ₹28.00 | -1.75% | 1,532 |
| 26-08-27 | ₹28.50 | +2.15% | 1,782 |
| 26-08-26 | ₹27.90 | +2.35% | 1,960 |
| 26-08-25 | ₹27.26 | -2.26% | 3,171 |
- Stock Market
- Stocks
- KIMIABL Stock
Select your edition
All financial news and data tailored to specific country editions
